PRVL
Prevail Therapeutics Inc. Common Stock
PRVL
PRVL
Delisted
PRVL was delisted on the 21st of January, 2021.
46 hedge funds and large institutions have $427M invested in Prevail Therapeutics Inc. Common Stock in 2019 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
+4
Holders Change %
+9.52%
% of All Funds
0.91%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
10
Increased
15
Reduced
8
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Point72 Asset Management
Stamford,
Connecticut
|
$5.8M |
| 2 |
2
BlackRock
New York
|
$11.3M |
| 3 |
3
Citadel Advisors
Miami,
Florida
|
$18.5M |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$1.22M |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$4.84M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Victory Capital Management
San Antonio,
Texas
| – | -$16K | -1,343 | Closed |
|